Outlook on the DNA Synthesis Technologies and Services Global Market to 2035 - Industry Trends and Forecasts

DUBLIN, June 21, 2022 /PRNewswire/ -- The "DNA Synthesis Technologies and Services Market, Distribution by Method of DNA Synthesis, Key Applications Areas, Company Size, and Key Geographies: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.

This report features report features a detailed study of the current scenario and future potential of the DNA synthesis technologies and service providers. Further, the study underlines an in-depth analysis, highlighting the capabilities of service providers engaged in this domain.

DNA or RNA molecules find a variety of applications in the biopharmaceutical industry for genetic testing, medical research, therapeutic development, forensic investigation, and other analytical processes. It is worth highlighting that several research studies are being conducted to evaluate the use of oligonucleotides, especially DNA, as a therapeutic intervention for treatment of various medical conditions.

The approval of the first antisense oligonucleotide drug, Fomivirse, in 1998, led to a surge in the demand of DNA-based interventions. In addition to the application of DNA in therapy development, these entities are also being deployed in genetic diagnostics and have already proven their use in identifying patients across a diverse range of diseases including breast cancer, dyslexia, ovarian cancer, Parkinson's disease and psoriasis.

The advances in medical research have led to establishment of several technologies that can sequence, analyze, and edit different forms of DNA. This, coupled to the increasing use of DNA across diverse range of applications, have urged industry experts to actively look for efficient DNA synthesis technologies that not only facilitate parallelized synthesis of DNA but also provide unmatched precision, scalability, and speed.

It is worth noting that several companies have developed proprietary enzymatic DNA synthesis platforms offering distinct advantages (such as the potential to increase length of DNA fragment, greater accessibility and convenience) over conventional DNA synthesis methods. Given the known merits of such technologies, a significant proportion of medical researchers and therapy / diagnostic developers prefer to outsource DNA synthesis operations to third party platforms / service providers who claim to provide the expertise in DNA synthesis and production.

Presently, there are over 65 players that offer DNA synthesis technologies / services, and these players are actively undertaking efforts to build / expand their existing capabilities, in order to cater to the growing demand for DNA synthesis. Given the rising need for DNA across a wide range of applications, we are led to believe that the DNA synthesis platforms and services industry is likely to witness noteworthy growth in the foreseen future. 

Key Questions Answered

• Who are the leading industry players offering DNA synthesis technologies and services?
• What are the recent developments and emerging trends in the DNA synthesis technologies and services domain?
• Which partnership models are commonly adopted by industry stakeholders in the DNA synthesis technologies and services industry?
• Which are the leading funding organizations providing grants in the DNA synthesis industry?
• What is the trend of capital investments in the DNA synthesis technologies and services market?
• What is the focus of various publications related to DNA synthesis technologies and services?
• How has the intellectual property landscape for DNA synthesis technologies and services market evolved over the years?
• Which factors are likely to influence the evolution of the upcoming DNA synthesis technologies and services market?
• How is the current and future opportunity likely to be distributed across key market segments?

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET OVERVIEW: DNA SYNTHESIS TECHNOLOGIES AND SERVICES
4.1. Chapter Overview
4.2. DNA Synthesis Technologies and Services: Overall Market Landscape
4.2.1. Analysis by Type of Offering
4.2.2. Analysis by Method of DNA Synthesis
4.2.3. Analysis by Type of DNA Molecule
4.2.4. Analysis by Custom Offerings
4.2.5. Analysis by Application Area
4.3. DNA Synthesis Technologies and Services: Key Industry Players
4.3.1 Analysis by Year of Establishment
4.3.2 Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Application Area and Region

5. COMPANY PROFILES
5.1. Chapter Overview
5.2. Ajinomoto Bio-Pharma Services
5.2.1. Company Overview
5.2.2. Financial Information
5.2.3. Technology / Service Portfolio
5.2.4. Recent Developments and Future Outlook
5.3. ATUM
5.3.1. Company overview
5.3.2. Technology / Service Portfolio
5.3.3. Recent Developments and Future Outlook
5.4. DNA Script
5.4.1. Company Overview
5.4.2. Technology / Service Portfolio
5.4.3. Recent Developments and Future Outlook
5.5. Eurofins Genomics
5.5.1. Company Overview
5.5.2. Financial Information
5.5.3. Technology / Service Portfolio
5.5.4. Recent Developments and Future Outlook
5.6. Gene Universal
5.6.1. Company Overview
5.6.2. Technology / Service Portfolio
5.6.3. Recent Developments and Future Outlook
5.7. GenScript
5.7.1. Company Overview
5.7.2. Financial Information
5.7.3. Technology / Service Portfolio
5.7.4. Recent Developments and Future Outlook
5.8. Synbio Technologies
5.8.1. Company overview
5.8.2. Technology / Service Portfolio
5.8.3. Recent Developments and Future Outlook

6. CASE STUDY: OLIGONUCLEOTIDE MANUFACTURERES (RESEARCH AND DIAGNOSTIC APPLICATIONS)
6.1. Chapter Overview
6.2. Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Overall Market Landscape
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Company Size
6.2.3. Analysis by Scale of Operation
6.2.4. Analysis by Geographical Location
6.2.5. Analysis by Location of Manufacturing Facilities
6.2.6. Analysis by Regulatory Accreditations / Certifications Received
6.2.7. Analysis by Type of Oligonucleotide Manufactured
6.2.8. Analysis by Type of Offering
6.2.9. Analysis by Type of Manufacturing Service Offered
6.2.10. Analysis by Type of Modification

7. CASE STUDY: OLIGONUCLEOTIDE MANUFACTURERES (THERAPEUTIC APPLICATIONS)
7.1. Chapter Overview
7.2. Oligonucleotide Manufacturers Focused on Therapeutic Applications: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Scale of Operation
7.2.4. Analysis by Geographical Location
7.2.5. Analysis by Location of Manufacturing Facilities
7.2.6. Analysis by Regulatory Accreditations / Certifications
7.2.7. Analysis by Type of Oligonucleotide Manufactured
7.2.8. Analysis by Type of Offering
7.2.9. Analysis by Type of Manufacturing Service Offered
7.2.10. Analysis by Type of Modification

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. DNA Synthesis Technologies and Services: List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Type of Partner
8.3.4. Analysis by Year and Type of Partner
8.3.5. Most Active Players: Analysis by Number of Partnerships
8.3.6. Regional Analysis
8.3.6.1. Intercontinental and Intracontinental Agreements

9. FUNDING AND INVESTMENT ANALYSIS
9.1. Chapter Overview
9.2. Types of Funding
9.3. DNA Synthesis Technologies: Recent Funding Instances
9.4. Analysis by Year of Investment
9.5. Analysis by Amount Invested
9.5. Analysis by Amount Invested
9.6. Analysis by Type of Funding and Amount Invested
9.7. Analysis by Venture Capital Funding
9.8. Most Active Players: Analysis by Number of Funding Instances
9.9. Key Investors: Analysis by Number of Funding Instances
9.10. Regional Analysis by Amount Invested
9.11. Funding and Investment Summary

10. GRANT ANALYSIS
10.1 Chapter Overview
10.2. Analysis Methodology and Key Parameters
10.3. DNA Synthesis Technologies and Services: List of Academic Grants
10.3.1. Analysis by Year of Grant Award
10.3.2. Analysis by Grant Amount Awarded
10.3.3. Analysis by Administering Institute Center
10.3.4. Analysis by Support Period
10.3.5. Analysis by Administering Institute Center and Support Period
10.3.6. Analysis by Type of Grant Application
10.3.7. Analysis by Grant Activity Code
10.3.8. Word Cloud of Study Titles
10.3.9. Analysis by Purpose of Grant Award
10.3.10. Popular NIH Departments: Analysis by Number of Grants
10.3.11. Analysis by Type of Recipient Organization
10..12. Prominent Program Officers: Analysis by Number of Grants

11. PUBLICATION ANALYSIS
11.1. Chapter Overview
11.2. Analysis Methodology and Key Parameters
11.3. Analysis by Year of Publication
11.4. Analysis by Quarterly Distribution of Publication
11.5. Analysis by Type of Article
11.6. Analysis by Popular Keywords
11.7. Most Popular Authors: Analysis by Number of Publications
11.8. Popular Publishers: Analysis by Number of Publications
11.9. Popular Journals: Analysis by Number of Publications
11.10. Analysis by Therapeutic Area
11.11. Geographical Analysis

12. PATENT ANALYSIS
12.1. Chapter Overview
12.2. Analysis Methodology and Key Parameters
12.3. DNA Synthesis Technologies and Services: Patent Analysis
12.3.1. Analysis by Type of Patent
12.3.2. Analysis by Publication Year
12.3.3. Analysis by Type of Patent and Publication Year
12.3.3. Analysis by Issuing Authority
12.3.4. Analysis by CPC Symbols
12.3.5. Analysis by Type of Applicant
12.3.6. Word Cloud Analysis: Emerging Focus Areas
12.3.7. Leading Industry Players: Analysis by Number of Patents
12.3.8. Leading Non-Industry Players: Analysis by Number of Patents
12.3.9. Leading Players: Analysis by Number of Patents
12.3.10. Leading Patents: International Patents
12.3.11. Analysis by Patent Characteristics
12.3.12. Patent Valuation Analysis

13. DNA SYNTHESIS SERVICES: MARKET FORECAST AND OPPORTUNITY ANALYSIS
13.1 Chapter Overview
13.2. Key Assumptions and Forecast Methodology
13.3. Global DNA Synthesis Services Market, 2022-2035
13.4. DNA Synthesis Services Market in North America, 2022-2035
13.5. DNA Synthesis Services Market in Europe, 2022-2035
13.6. DNA Synthesis Services Market in Asia-Pacific and Rest of the World, 2022-2035

14. CONCLUDING REMARKS

15. APPENDIX 1: TABULATED DATA

16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION

For more information about this report visit https://www.researchandmarkets.com/r/zar8u6

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets